Infant Bacterial Therapeutics AB had a revenue of 0.00 in the quarter ending Jun 30, 2025, with ―. This bring the company's revenue in the last twelve months to -1.00K, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, Infant Bacterial Therapeutics AB had annual revenue of 4.00K with -94.81% growth.